Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting
Therapeutic Innovation & Regulatory Science · 2024
DOI: 10.1007/s43441-024-00617-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Annett Keller und 10 weiteren Autor:innen. Beteiligte Einrichtung: Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH &Co. KG, Binger Strasse 173, 55216, Ingelheim, Germany. annett.keller@boehri…. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
The past years have sharpened the industry's understanding of a Quality by Design (QbD) approach toward clinical trials. Using QbD encourages designing quality into a trial during the planning phase. The identification of Critical to Quality (CtQs) factors and specifically Critical Data and Processes (CD&Ps) is key to such a risk-based monitoring approach. A variable that allows monitoring the evolution of risk regarding the CD&Ps is called a Quality Tolerance Limit (QTL) parameter. These parameters are linked to the scientific question(s) of a trial and may identify the issues that can jeopardize the integrity of trial endpoints. This paper focuses on defining what QTL parameters are and providing general guidance on setting thresholds for these parameters allowing for the derivation of an acceptable range of the risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH &Co. KG, Binger Strasse 173, 55216, Ingelheim, Germany. annett.keller@boehringer-ingelheim.com.
- Integrated Data Analytics and Reporting, Janssen Research and Development, Graaf Engelbertlaan 75, 4837DS, Breda, Netherlands.
- Global Data Management and Standards, Merck & Co., Inc, 770 Sumneytown Pike, West Point, PA, 19486, USA.
- Statistical Research and Innovation, Pfizer, 100 Cambridge Park Drive, Cambridge, MA, 02140, USA.
- Risk Evaluation and Adaptive Integrated Monitoring, MSD, V. F.lli Cervi, Palazzo Canova, 20090, Segrate, Milan, Italy.
- Risk Based Quality Management, Daiichi Sankyo, 211 Mount Airy Rd, Basking Ridge, NJ, 07920, USA.
ORCID-Profile: Annett Keller
Zitieren
APA
Keller, A., van Borrendam, N., Benner, P., Gilbert, S., Saino, S., Jendrasek, D., Young, S., Muli, M., Wang, J., Kozińska, M., & Liu, J. (2024). Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00617-6
Vancouver
Keller A, van Borrendam N, Benner P, Gilbert S, Saino S, Jendrasek D, et al. Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00617-6
BibTeX
@article{Keller2024,
author = {Keller, Annett and van Borrendam, Nathalie and Benner, Patrice and Gilbert, Steven and Saino, Stefano and Jendrasek, Debra and Young, Steve and Muli, Marcus and Wang, Jim and Kozińska, Marta and Liu, Jun},
title = {Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2024},
doi = {10.1007/s43441-024-00617-6}
}
EUVIMED